Campus health and safety are our top priorities. Get the latest from UT on COVID-19.
Scientists at The University of Texas at Austin have developed a new method to rapidly detect a single virus in urine, as reported this week in the journal Proceedings of the National Academy of Sciences.
Researchers at the University of Texas at Austin have for the first time revealed how a group of drugs that are being developed to treat hepatitis C works. Pharmaceutical companies might be able to apply these new insights to future drugs designed to address a deadly disease.
David Herrin, University of Texas at Austin professor of molecular biosciences, led a team of researchers which has developed algae that produce chemicals toxic to disease-carrying mosquitoes.
Researchers at The University of Texas at Austin successfully culminated years of work when a drug they engineered for the treatment and prevention of inhalational anthrax — the anthrax antitoxin obiltoxaximab — received approval March 21 from the U.S. Food and Drug Administration (FDA).
To study diseases, biologists often make models, for example, a rat with a disorder similar to Alzheimer's. With a good model, they can tinker with different variables and see if anything halts the disease, without the ethical limits of experimenting on actual humans. But scientists studying an especially nasty bacterium that tends to invade and breed out of control in the lungs of people with cystic fibrosis (CF) kept hitting dead ends in their search for a good model.
Undergraduate researchers in UT Austin's Freshman Research Initiative (FRI) join the effort to develop a readily available test for the newly spreading Zika virus.
The most dangerous times of year for children with asthma are soon after their schools reopen after a break, and a new study finds that cold viruses are largely to blame.
A research center at The University of Texas at Austin will be renamed for Dr. John Ring LaMontagne, a scientist who combated flu and other infectious diseases to improve public health around the globe. The renaming of the existing Center for Infectious Disease follows more than $7 million in contributions by the LaMontagne community of family, friends and colleagues in celebration of Dr. Montagne's work within the National Institutes of Health (NIH).
Scientists at The University of Texas at Austin have discovered that a protein produced by the influenza A virus, which causes flu, can overcome one of our body's natural defense mechanisms. That makes this flu protein a potentially good target for antiviral drugs directed against the flu virus
Researchers studying a dangerous type of bacteria have discovered that the bacteria have the ability to block both their own growth and the growth of their antibiotic-resistant mutants. The discovery might lead to better ways to fight a class of bacteria that have contributed to a growing public health crisis by becoming increasingly resistant to antibiotic treatments.
Read our publication, The Texas Scientist, a digest covering the people and groundbreaking discoveries that make the College of Natural Sciences one of the most amazing and significant places on Earth.
